Julian Panés Selected Research

Julian Panés Research Topics

Disease

21	Ulcerative Colitis 10/2022 - 07/2014
20	Crohn Disease (Crohn's Disease) 11/2022 - 09/2008
5	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 10/2022 - 01/2015
3	Herpes Zoster 10/2022 - 01/2017
3	Infections 10/2022 - 01/2017
3	Skin Neoplasms (Skin Cancer) 01/2022 - 01/2017
3	Inflammation (Inflammations) 03/2021 - 01/2016
2	Fistula 11/2022 - 01/2022
2	Abdominal Pain (Pain, Abdominal) 10/2022 - 01/2022
2	Hemorrhage 01/2022 - 01/2021
2	Necrosis 01/2022 - 03/2021
2	Pathologic Constriction (Stenosis) 01/2018 - 11/2013
2	Disease Progression 12/2013 - 11/2013
1	Choristoma (Ectopic Tissue) 11/2022
1	Acne Vulgaris 01/2022
1	Nasopharyngitis 01/2022
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2022
1	Arthralgia (Joint Pain) 01/2022
1	Neoplasms (Cancer) 01/2021
1	Rheumatoid Arthritis 01/2021
1	Psoriatic Arthritis 01/2021
1	COVID-19 01/2021
1	Ulcer 09/2020
1	Venous Thrombosis (Deep-Vein Thrombosis) 11/2019
1	Venous Thromboembolism 11/2019
1	Pulmonary Embolism 11/2019
1	Mucositis 01/2016

Drug/Important Bio-Agent (IBA)

15	tofacitinibIBA 06/2022 - 01/2016
11	Janus Kinase InhibitorsIBA 06/2022 - 11/2016
4	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 07/2010
3	Leukocyte L1 Antigen Complex (Calgranulin)IBA 10/2022 - 07/2014
3	upadacitinibIBA 10/2022 - 11/2021
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2021 - 11/2020
2	Pharmaceutical PreparationsIBA 10/2022 - 10/2017
2	Creatine Kinase (Creatine Phosphokinase)IBA 10/2022 - 01/2022
2	Tumor Necrosis Factor InhibitorsIBA 06/2022 - 01/2017
2	Janus Kinase 1IBA 01/2022 - 11/2021
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 07/2014
2	Adalimumab (Humira)FDA Link 01/2022 - 12/2013
2	IntegrinsIBA 12/2021 - 10/2017
2	Janus KinasesIBA 11/2021 - 01/2018
2	Biological ProductsIBA 01/2021 - 09/2020
2	Infliximab (Remicade)FDA Link 01/2015 - 07/2010
2	Azathioprine (Imuran)FDA LinkGeneric 11/2013 - 09/2008
1	C-Reactive ProteinIBA 10/2022
1	Contrast MediaIBA 05/2022
1	risankizumabIBA 01/2022
1	etrolizumabIBA 01/2022
1	Ustekinumab (CNTO 1275)FDA Link 01/2022
1	Saline SolutionIBA 01/2022
1	InterleukinsIBA 01/2022
1	AntibodiesIBA 12/2021
1	InterferonsIBA 11/2021
1	vedolizumabIBA 03/2021
1	GadoliniumIBA 09/2020
1	Phenobarbital (Luminal)FDA Link 09/2020
1	Capsules (Microcapsules)IBA 01/2018
1	LipidsIBA 01/2017
1	CytokinesIBA 01/2016
1	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 01/2016
1	Proteins (Proteins, Gene)FDA Link 01/2016
1	Biosimilar PharmaceuticalsIBA 01/2015
1	Immunologic Factors (Immunomodulators)IBA 11/2013
1	Methotrexate (Mexate)FDA LinkGeneric 11/2013
1	Mercaptopurine (6 Mercaptopurine)FDA LinkGeneric 11/2013
1	Certolizumab Pegol FDA Link 07/2010
1	SteroidsIBA 09/2008
1	Everolimus FDA Link 09/2008

Therapy/Procedure

12	Therapeutics 10/2022 - 02/2012
3	Remission Induction 11/2022 - 01/2022
3	Aftercare (After-Treatment) 11/2022 - 11/2021
3	Stem Cell Transplantation 10/2017 - 01/2016
2	Biological Therapy 05/2022 - 01/2022
1	Curettage 01/2022
1	Drug Tapering 07/2021
1	Artificial Respiration (Mechanical Ventilation) 01/2021
1	Transplantation 09/2016